Domestic Violence Clinical Trial
Official title:
The Effect of Fluoxetine on Measures of Domestic Violence
Verified date | June 2, 2010 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will evaluate whether fluoxetine (Prozac), used together with traditional
psychotherapy, can reduce aggression in people who are physically violent towards their
spouses or significant others. Treatment for domestic violence has centered on behavioral
therapies, such as anger management and self-control exercises. Recent studies have shown
that fluoxetine-a drug commonly used to treat depression and panic disorder-can decrease acts
of aggression.
Men and women between the ages of 18 and 65 who have a history of inflicting physical
aggression on a spouses or significant others in the past year (with at least one episode
occurring not under the influence of alcohol) may be eligible for this study. Participants
spouses or significant others will also be asked to participate. All potential participants
will be screened with a medical and psychiatric evaluation and history, breath alcohol
analysis, blood tests, urine drug screen and electrocardiogram.
Those enrolled will undergo the following procedures:
Perpetrator
- Interview and questionnaires - Participants will be interviewed by a social worker about
past and current mental health and use of alcohol and illicit drugs and will complete
questionnaires assessing emotional state and personality, depression, anxiety,
aggression and alcohol consumption. Some of the questionnaires will be repeated at
monthly intervals.
- Physical performance testing - Performance and speed will be measured in three separate
training sessions that involve repeatedly pressing a button on a button box console,
earning points worth money.
- Dyadic interaction paradigm - Participants will interact with their spouse/significant
other in a small room, first discussing a neutral topic, such as the day's events, and
then a subject that has been a source of conflict.
- Fluoxetine administration - Participants will be randomly assigned to receive either 10
mg. of fluoxetine or placebo (identical capsules with no active ingredients) once a day
for 3 days, then twice a day, increasing up to four capsules a day if there are no
serious side effects. Blood will be drawn once a month to measure drug levels. At the
end of 3 months, participants taking placebo may remain in the study and receive
fluoxetine.
- Clinic visits - Participants are followed in the clinic weekly for the first month, then
twice a month for the next 2 months for adjustment of number of pills, evaluation of
aggressive behavior and alcohol consumption, and therapy for issues of self-esteem,
anger management and communication skills. Couples therapy aimed at conflict resolution
and improving communication skills will be offered.
- Genetic tests (optional) - Blood will be drawn to determine if there is a relationship
between genes involved in a chemical process (serotonin reuptake) that is influenced by
fluoxetine and the participant's response to the drug.
Spouse/Significant other:
Spouses/significant others will complete several questionnaires once a month (total 4 times)
to rate their partners' behavior while in the study. They will also participate in the dyadic
interaction paradigm described above at the beginning and end of the study.
Status | Completed |
Enrollment | 104 |
Est. completion date | February 26, 2007 |
Est. primary completion date | February 26, 2007 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
- INCLUSION CRITERIA: Men and women over the age of 18 will be eligible for the study if they have: A history of at least two episodes of physical aggression (i.e., hitting, pushing, punching, choking etc.) toward their spouse or significant other in the past year; A history of at least one episode of physical aggression toward their spouse or significant other which occurred when the perpetrator had not used alcohol/drugs for at least a day; A score of at least 3 on the Straus Conflict Tactics physical violence subscale; A signed informed consent for participation in the protocol; and Agreed to provide investigators with phone numbers of family and/or friends who will be able to provide information about the perpetrators' whereabouts in the event that the perpetrator does not come to appointments. EXCLUSION CRITERIA: Participants under the age of 18 will be excluded from the protocol because the generalizability of the results could potentially be compromised; Abnormal laboratory or diagnostic tests which are judged to be clinically significant; History of schizophrenia or bipolar disorder; Participants judged to be a significant suicide/homicide risk; Head trauma resulting in a period of unconsciousness lasting longer than one hour; Documented seizure disorder (alcohol withdrawal seizures are not exclusionary); History of a major medical problem (i.e., diabetes, cancer); Women with a positive pregnancy test or women of childbearing age who are not willing to use some form of birth control during the study; Participants whose spouse/significant other is pregnant; Participants using an SSRI on a regular basis in the last three months; Participants requiring other psychotropic medications; Perpetrators requiring medications that inhibit CYP2D6, and could potentially interact with fluoxetine; Individuals who are unwilling to forgo access to guns for the duration of the study; Participants who are very controlling and are currently stalking their partner; Participants who engage in forced sex; Participants whose spouse/significant other feel that they are in great danger; and Participants participating in the functional MRI paradigm will be excluded if they have ferromagnetic objects in their bodies which might be aversely affected by MRI (e.g., surgical clips; metal fragments in or near brain, eye, or blood vessels; cardiac or neurological pacemaker; cochlear or eye implant). |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 1994 May;17(5):208-14. Review. — View Citation
Goldberg WG, Tomlanovich MC. Domestic violence victims in the emergency department. New findings. JAMA. 1984 Jun 22-29;251(24):3259-64. — View Citation
Pitts FN Jr, McClure JN Jr. Lactate metabolism in anxiety neurosis. N Engl J Med. 1967 Dec 21;277(25):1329-36. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03037749 -
Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
|
N/A | |
Completed |
NCT02606344 -
Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV
|
N/A | |
Completed |
NCT03482687 -
It's Your Game: An Innovative Approach to Preventing Teen Dating Violence
|
N/A | |
Active, not recruiting |
NCT00847548 -
Treatment of Intimate Partner Violence and Substance Abuse in a Forensic Setting
|
N/A | |
Completed |
NCT01207258 -
Brief Intervention for Problem Drinking and Partner Violence
|
Phase 2 | |
Completed |
NCT00983593 -
A Randomized Clinical Study of a Mind-Body Approach to Domestic Violence Offender Treatment
|
N/A | |
Completed |
NCT01621334 -
The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use
|
Phase 1 | |
Completed |
NCT01803932 -
Evaluation of a Male-focused Intervention to Prevent Intimate Partner Violence in a Conflict-affected Setting
|
N/A | |
Completed |
NCT00289939 -
Reducing HIV & Domestic Violence Risk in Women Offenders
|
Phase 3 | |
Completed |
NCT05598697 -
Economic Evaluation of the MEWE Intervention
|
N/A | |
Not yet recruiting |
NCT03672942 -
Communication Skills vs. Mindfulness for IPV
|
N/A | |
Completed |
NCT03883932 -
Fatherhood Focused Family Violence Education Program
|
N/A | |
Completed |
NCT05129501 -
The Impact of an Adapted Version of the Strengthening Families Program on IPV Among Caregivers and ACEs Among Children
|
N/A | |
Enrolling by invitation |
NCT05139069 -
Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women
|
N/A | |
Recruiting |
NCT03198429 -
Cluster RCT of Embedded Parenting Intervention to Prevent Recurrence and Reduce Impairment in Young Children Exposed to Domestic Violence
|
N/A | |
Completed |
NCT04125251 -
Men Engagement in Women Empowerment for Improving Maternal Mental Health Through Cash Transfer and Life Skills Building
|
N/A | |
Active, not recruiting |
NCT03236948 -
RCT of the Effectiveness of the WfWI Intervention in Afghanistan
|
Phase 3 | |
Completed |
NCT02258841 -
Effectiveness of an Online Safety Tool for Canadian Women Experiencing Intimate Partner Violence
|
N/A | |
Completed |
NCT01958554 -
Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence
|
Phase 2 | |
Completed |
NCT01688427 -
Perinatal Nurse Home Visiting Enhanced With mHealth Technology
|
N/A |